Efficacy of gadoxetic acid-enhanced MRI in assessing tumor regression after radiofrequency ablation for hepatocellular carcinoma - comparison with CT
Not Applicable
Recruiting
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000004571
- Lead Sponsor
- Tokai University School of Medicine Department of Gastroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients having allergy to Gd. 2. Patients having allergy to iodine. 3. Patients with eGFR less than 30 mL/min/1.73 m2 4. Patients with sever heart or lung diseases 5. Patients with asthma 6. Patients with uncontrolled other malignancies
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of RFA treatment
- Secondary Outcome Measures
Name Time Method